Cognitive Deficit Clinical Trials
2 recruiting trials for Cognitive Deficit. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cognitive Deficit clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Alliance Equiphoria (1), Francisco Gonzalez-Lima, PhD (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Hippotherapy (other, 1 trial), followed by Conventional Neurorehabilitation, Transcranial photobiomodulation.
Track Cognitive Deficit trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Neurorehabilitation Through Hippotherapy of a Brain Stroke
Cerebrovascular accident \[CVA\] (medical term for stroke) is a high burden worldwide disorder and the second leading cause of disability. As illustrated by the number of...
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Inattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cognitive Deficit, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cognitive Deficit, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cognitive Deficit, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.